HIV-1 RNA Levels in Cerebrospinal Fluid and Plasma and Their Correlation with Opportunistic Neurological Diseases in a Brazilian AIDS Reference Hospital
Overview
Psychiatry
Affiliations
Background: Plasma HIV RNA levels reflect systemic viral replication but in CNS it may occur relatively independent of systemic infection, yet clinical application of CSF HIV-1 RNA levels is less clear.
Objective: To compare CSF and plasma HIV-1 RNA levels of patients with different opportunistic neurological diseases to those without neurological disease, as well as to correlate these levels with the outcome of the disease and use of HAART.
Method: 97 patients who had lumbar puncture for routine work up of suspected neurological diseases, were divided in 2 groups: without neurological disease (23) and with neurological disease (74). NASBA was used for plasma and CSF HIV RNA.
Results: Median CSF viral load was higher in toxoplasmic encephalitis, cryptococcal meningitis, HIV dementia and neurological diseases without a defined etiology when compared to patients without neurological disease. There was no difference between plasma viral load in patients with and without neurological diseases. Median viral load was higher in plasma and CSF among patients who died when compared to those successfully treated. CSF and plasma viral load were lower in patients with opportunistic diseases on HAART than without HAART.
Conclusion: CSF viral load was higher in patients with any neurological disease, but this difference was not present in plasma viral load, suggesting that neurological disease influences more the CSF than plasma compartments. Notwithstanding different neurological diseases were not possible to be differentiated by the levels of CSF HIV-1.
Kelly S, Nightingale S, Gupta R, Collier D Trop Med Infect Dis. 2025; 10(2).
PMID: 39998049 PMC: 11860496. DOI: 10.3390/tropicalmed10020045.
In situ analysis of neuronal injury and neuroinflammation during HIV-1 infection.
Honeycutt J, Wahl A, Files J, League A, Yadav-Samudrala B, Garcia J Retrovirology. 2024; 21(1):11.
PMID: 38945996 PMC: 11215835. DOI: 10.1186/s12977-024-00644-z.
Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana.
Kelentse N, Moyo S, Molebatsi K, Morerinyane O, Bitsang S, Bareng O Biomedicines. 2022; 10(6).
PMID: 35740421 PMC: 9219642. DOI: 10.3390/biomedicines10061399.
Human Immunodeficiency Virus in the Brain-Culprit or Facilitator?.
Ene L Infect Dis (Auckl). 2018; 11:1178633717752687.
PMID: 29467577 PMC: 5815409. DOI: 10.1177/1178633717752687.
Neurological complications of HIV infection in pre-HAART and HAART era: a retrospective study.
Matinella A, Lanzafame M, Bonometti M, Gajofatto A, Concia E, Vento S J Neurol. 2015; 262(5):1317-27.
PMID: 25877836 DOI: 10.1007/s00415-015-7713-8.